期刊文献+

常见多重耐药菌的耐药机制及防治对策 被引量:145

在线阅读 下载PDF
导出
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2006年第12期1434-1437,共4页 Chinese Journal of Nosocomiology
  • 相关文献

参考文献16

  • 1潘劲草,刘克洲.整合子在革兰阴性菌获得性耐药形成机制中的作用[J].国外医学(流行病学.传染病学分册),2004,31(5):289-291. 被引量:8
  • 2[2]Xiong ZZ,Zhu DM,Wang FA.Klebsiella pneumoniae producing three kinds of class A β-lactamases encoded by single plasmid isolated from a patient in Huashan Hospital,Shanghai,China[J].Int J Antimicrob Agents,2004,23(3):262-267.
  • 3[3]Rosser SJ,Young HK.Identification and characterization of class 1 integrons in bacteria from an aquatic environment[J].J Antimicrob Chemother,1999,44(1):11-18.
  • 4[4]Rowe-Magnus DA,Guerout AM,Mazel D.Bacterial resistance evolution by recruitment of super-integron gene cassettes[J].Mol Microbiol,2002,43(6):1657-1669.
  • 5[5]Leverstein-van Hall MA,Blok MHE,Donders TAR,et al.Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin[J].J Infect Dis,2003,187(2):251-259.
  • 6[6]Tsakris A,Pournaras S,Woodford N,et al.Outbreak of infections caused by Pseudomonas aerugiosa producing VIM-1 carbapenemase in Greece[J].J Clin Microbiol,2000,38(3):1290-1292.
  • 7曹彬,王辉,朱元珏,陈民钧.多药耐药铜绿假单胞菌院内感染危险因素及预后因素分析[J].中华结核和呼吸杂志,2004,27(1):31-35. 被引量:199
  • 8王辉,陈民钧.碳青霉烯酶:未来困扰我们的难题[J].中华内科杂志,2003,42(5):354-356. 被引量:62
  • 9赵云峰,罗永艾.耐药结核病的现状及防治[J].中国实用内科杂志,2004,24(8):451-454. 被引量:8
  • 10[10]Yu WL,Chuang YC,Jones RN.A pragmatic approach to identify extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Taiwan:in vitro activity of newer and established antimicrobial agents[J].Diagn Microbiol Infect Dis,2004,48(4):277-282.

二级参考文献97

  • 1潘晞.结核分支杆菌耐药性研究进展[J].中国防痨杂志,1997,19(1):43-46. 被引量:11
  • 2马绪荣 刘鸿印 江元培et al 见:郑钧镛 王光宝主编.药物敏感性试验法[A].见:郑钧镛,王光宝主编.药品微生物及检验技术[C].北京:人民卫生出版社,1985.349~51.
  • 3周邦靖.中药抗菌效力的测定方法[A].见:周邦靖主编.常用中药的抗菌作用及其测定方法[C].重庆:科学技术文献出版社重庆分社,1987.289~308.
  • 4Tsakris A, Pournaras S, Woodford N, et al. Outbreak d infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol, 2000.38: 1290-1292.
  • 5Poirel L, Naas T, Nicolas D, et al. Characterization d VIM-2, a carbapanem-hydrolyzing metallo-beta-lactamase and its plasmid-and integron-borne gene from a Psedomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000.44: 891-897.
  • 6Yah J, Hsueh P, Ko W, et al. Metallo-beta-lactamase in clinical Psedumonas isolates in Taiwan and identification d VIM-3, a novel variant of VIM-2 enzyme. Antimicrob Agents Chemother, 2001,45 :2224-2228.
  • 7Yum JH, Yi K, Lee H, et al. Molecular characterization of metallobeta-lactamase-producing Acinetobacter bsumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla (VIM-2) gene cassettes. J Antimicrob Chemother,2002, 49: 837-840.
  • 8Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother, 2000, 44:1556-1561.
  • 9Afzal-Shah M,Woodford N,Liermore DM,Characterization of OXA-25,OXA-26,and OXA-27,molecular class D bet-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.Antimicrob Agents Chemother,2001,45:583-588.
  • 10Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect, 2002, 8: 321-331.

共引文献448

同被引文献930

引证文献145

二级引证文献866

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部